Variant report

Variant	nsv1037938
Chromosome Location	chr12:85902517-86045125
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:941)
CpG islands
(count:122)
Chromatin interactive
region (count:29)
LncRNA
region (count:1)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:941 , 50 per page) page: 1 2 3 4 5 6 7 ... 19

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr12:85943398-85943797	HepG2	liver:	n/a	n/a
2	ARID3A	chr12:86036581-86037005	HepG2	liver:	n/a	n/a
3	ATF2	chr12:85920866-85921402	GM12878	blood:	n/a	n/a
4	BATF	chr12:85929686-85929979	GM12878	blood:	n/a	n/a
5	BCL11A	chr12:85903612-85903886	GM12878	blood:	n/a	n/a
6	BHLHE40	chr12:85903677-85903924	GM12878	blood:	n/a	n/a
7	BHLHE40	chr12:85925172-85925543	GM12878	blood:	n/a	n/a
8	BRCA1	chr12:86019903-86020631	Hela-S3	cervix:	n/a	n/a
9	CBX3	chr12:86020121-86020665	HCT-116	colon:	n/a	n/a
10	CEBPB	chr12:85948894-85949140	A549	lung:	n/a	chr12:85949046-85949057 chr12:85949018-85949029
11	CEBPB	chr12:86027250-86027714	HCT-116	colon:	n/a	n/a
12	CEBPB	chr12:86020204-86020533	A549	lung:	n/a	n/a
13	CEBPB	chr12:86036533-86037022	MCF-7	breast:	n/a	chr12:86036746-86036757
14	CEBPB	chr12:85916987-85917438	Hela-S3	cervix:	n/a	chr12:85917175-85917188
15	CEBPB	chr12:85942408-85942794	A549	lung:	n/a	chr12:85942416-85942428
16	CEBPB	chr12:86036563-86036936	MCF-7	breast:	n/a	chr12:86036746-86036757
17	CEBPB	chr12:86028843-86029069	HepG2	liver:	n/a	n/a
18	CEBPB	chr12:86019830-86021039	IMR90	lung:	n/a	chr12:86020651-86020662
19	CEBPB	chr12:85943425-85943748	A549	lung:	n/a	n/a
20	CEBPB	chr12:86020158-86020619	A549	lung:	n/a	n/a
21	CEBPB	chr12:86021336-86021743	IMR90	lung:	n/a	n/a
22	CEBPB	chr12:86021300-86021775	Hela-S3	cervix:	n/a	n/a
23	CEBPB	chr12:86020105-86020665	HCT-116	colon:	n/a	chr12:86020651-86020662
24	CEBPB	chr12:85957585-85957738	Hela-S3	cervix:	n/a	chr12:85957676-85957689 chr12:85957676-85957689 chr12:85957676-85957687 chr12:85957676-85957689 chr12:85957676-85957687
25	CEBPB	chr12:85966835-85967062	Hela-S3	cervix:	n/a	n/a
26	CEBPB	chr12:85942473-85942800	HepG2	liver:	n/a	n/a
27	CEBPB	chr12:86036542-86036989	Hela-S3	cervix:	n/a	chr12:86036746-86036757
28	CEBPB	chr12:86002098-86002319	A549	lung:	n/a	n/a
29	CEBPB	chr12:86019722-86020633	Hela-S3	cervix:	n/a	n/a
30	CEBPB	chr12:86036545-86036953	IMR90	lung:	n/a	chr12:86036746-86036757
31	CEBPB	chr12:86036612-86036933	H1-hESC	embryonic stem cell:	n/a	chr12:86036746-86036757
32	CEBPB	chr12:86002046-86002376	HepG2	liver:	n/a	n/a
33	CEBPB	chr12:85978878-85979088	A549	lung:	n/a	chr12:85978973-85978986 chr12:85978973-85978984 chr12:85978975-85978984 chr12:85978974-85978985 chr12:85978973-85978986 chr12:85978975-85978984 chr12:85978975-85978984 chr12:85978973-85978986 chr12:85978975-85978984
34	CEBPB	chr12:85942503-85942765	H1-hESC	embryonic stem cell:	n/a	n/a
35	CEBPB	chr12:86020007-86020716	HCT-116	colon:	n/a	chr12:86020651-86020662
36	CEBPB	chr12:86036576-86036938	A549	lung:	n/a	chr12:86036746-86036757
37	CEBPB	chr12:86036618-86036904	HepG2	liver:	n/a	chr12:86036746-86036757
38	CEBPB	chr12:86032813-86033108	HepG2	liver:	n/a	chr12:86033071-86033083
39	CEBPB	chr12:85981876-85982197	Hela-S3	cervix:	n/a	n/a
40	CEBPB	chr12:85981944-85982144	H1-hESC	embryonic stem cell:	n/a	n/a
41	CEBPB	chr12:86036462-86037083	HCT-116	colon:	n/a	chr12:86036746-86036757
42	CEBPB	chr12:85943405-85943769	HepG2	liver:	n/a	n/a
43	CEBPB	chr12:86036541-86036964	HepG2	liver:	n/a	chr12:86036746-86036757
44	CEBPB	chr12:85948898-85949146	HepG2	liver:	n/a	chr12:85949046-85949057 chr12:85949018-85949029
45	CEBPB	chr12:86036609-86036880	HepG2	liver:	n/a	chr12:86036746-86036757
46	CEBPB	chr12:86036562-86036986	A549	lung:	n/a	chr12:86036746-86036757
47	CEBPB	chr12:85978809-85979116	HepG2	liver:	n/a	chr12:85978973-85978986 chr12:85978973-85978984 chr12:85978975-85978984 chr12:85978974-85978985 chr12:85978973-85978986 chr12:85978975-85978984 chr12:85978975-85978984 chr12:85978973-85978986 chr12:85978975-85978984
48	CEBPB	chr12:85942491-85942784	A549	lung:	n/a	n/a
49	CEBPB	chr12:86036559-86036960	HepG2	liver:	n/a	chr12:86036746-86036757
50	CEBPB	chr12:86020186-86020596	A549	lung:	n/a	n/a

(count:122 , 50 per page) page: 1 2 3

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr12:85945089-85945139	HMEC	breast:	n/a
2	chr12:85945089-85945139	NB4	blood:	n/a
3	chr12:86040467-86040517	NB4	blood:	n/a
4	chr12:86040467-86040517	HCF	heart:	n/a
5	chr12:85945089-85945139	HEEpiC	esophagus:	n/a
6	chr12:85945089-85945139	GM06990	blood:	n/a
7	chr12:85945089-85945139	AG09309	skin:	n/a
8	chr12:85945089-85945139	MCF-7	breast:	n/a
9	chr12:86040467-86040517	HRPEpiC	eye:	n/a
10	chr12:86040467-86040517	ovcar-3	ovarian:	n/a
11	chr12:86040467-86040517	SK-N-SH_RA	brain:	n/a
12	chr12:86040467-86040517	HRE	kidney:	n/a
13	chr12:85945089-85945139	AG10803	skin:	n/a
14	chr12:85945089-85945139	CMK	blood:	n/a
15	chr12:85945089-85945139	SAEC	small airway:	n/a
16	chr12:86040467-86040517	HEK293	kidney:	embryo
17	chr12:86040467-86040517	HEEpiC	esophagus:	n/a
18	chr12:85945089-85945139	ovcar-3	ovarian:	n/a
19	chr12:86040467-86040517	RPTEC	kidney:	n/a
20	chr12:85945089-85945139	RPTEC	kidney:	n/a
21	chr12:86040467-86040517	HCT-116	colon:	n/a
22	chr12:86040467-86040517	ProgFib	skin:	n/a
23	chr12:85945089-85945139	HCF	heart:	n/a
24	chr12:85945089-85945139	BJ	skin:	n/a
25	chr12:85945089-85945139	HAEpiC	amniotic membrane:	n/a
26	chr12:86040467-86040517	Jurkat	blood:	n/a
27	chr12:86040467-86040517	HRCEpiC	kidney:	n/a
28	chr12:86040467-86040517	SK-N-MC	brain:	n/a
29	chr12:85945089-85945139	SK-N-SH	brain:	n/a
30	chr12:85945089-85945139	GM12892	blood:	n/a
31	chr12:85945089-85945139	HUVEC	blood vessel:	n/a
32	chr12:86040467-86040517	CMK	blood:	n/a
33	chr12:86040467-86040517	NHBE	bronchial:	n/a
34	chr12:85945089-85945139	HPAEpiC	pulmonary alveolar:	n/a
35	chr12:85945089-85945139	AG04450	lung:	fetal
36	chr12:85945089-85945139	SK-N-MC	brain:	n/a
37	chr12:86040467-86040517	MCF10A-Er-Src	breast:	n/a
38	chr12:85945089-85945139	NT2-D1	testis:	n/a
39	chr12:85945089-85945139	A549	lung:	n/a
40	chr12:85945089-85945139	HRCEpiC	kidney:	n/a
41	chr12:86040467-86040517	AG04449	skin:	fetal
42	chr12:85945089-85945139	AG09319	gingival:	n/a
43	chr12:86040467-86040517	HUVEC	blood vessel:	n/a
44	chr12:85945089-85945139	HCPEpiC	choroid plexus:	n/a
45	chr12:85945089-85945139	LNCaP	prostate:	n/a
46	chr12:85945089-85945139	GM12878	blood:	n/a
47	chr12:86040467-86040517	NH-A	brain:	n/a
48	chr12:86040467-86040517	HCPEpiC	choroid plexus:	n/a
49	chr12:86040467-86040517	BJ	skin:	n/a
50	chr12:85945089-85945139	ProgFib	skin:	n/a

(count:29 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr12:86002253..86004144-chr12:86006143..86008700,2	MCF-7	breast:
2	chr12:86008021..86010789-chr12:86012957..86015625,2	MCF-7	breast:
3	chr12:85908005..85909863-chr12:85911172..85913825,2	MCF-7	breast:
4	chr12:85940120..85942691-chr12:85944053..85946791,2	MCF-7	breast:
5	chr12:86036224..86038282-chr12:86040678..86042966,2	MCF-7	breast:
6	chr12:85916869..85918658-chr12:85921402..85924342,2	K562	blood:
7	chr12:85916869..85918658-chr12:85921402..85924342,2	K562	blood:
8	chr12:85956037..85957820-chr12:85959579..85961160,2	K562	blood:
9	chr12:86031568..86033990-chr12:86035290..86037133,2	K562	blood:
10	chr12:85930199..85932678-chr12:85934950..85937006,2	K562	blood:
11	chr12:86031568..86033990-chr12:86035290..86037133,2	K562	blood:
12	chr12:85905968..85908916-chr17:58676509..58679332,2	MCF-7	breast:
13	chr12:85940120..85942691-chr12:85944053..85946791,2	MCF-7	breast:
14	chr12:86014804..86017595-chr12:86018520..86021053,2	MCF-7	breast:
15	chr12:85968890..85970646-chr12:86260113..86261752,8	MCF-7	breast:
16	chr12:85972333..85972969-chr12:86260657..86261419,2	MCF-7	breast:
17	chr12:85972231..85974209-chr12:85975781..85977996,2	MCF-7	breast:
18	chr12:85930199..85932678-chr12:85934950..85937006,2	K562	blood:
19	chr12:85908005..85909863-chr12:85911172..85913825,2	MCF-7	breast:
20	chr12:85949711..85951775-chr12:85954587..85956542,2	K562	blood:
21	chr12:86008021..86010789-chr12:86012957..86015625,2	MCF-7	breast:
22	chr12:85972231..85974209-chr12:85975781..85977996,2	MCF-7	breast:
23	chr12:85969213..85970141-chr12:86036344..86037184,4	MCF-7	breast:
24	chr12:85956037..85957820-chr12:85959579..85961160,2	K562	blood:
25	chr12:85949711..85951775-chr12:85954587..85956542,2	K562	blood:
26	chr12:86002253..86004144-chr12:86006143..86008700,2	MCF-7	breast:
27	chr12:85969245..85970171-chr12:86260729..86261622,3	MCF-7	breast:
28	chr12:86014804..86017595-chr12:86018520..86021053,2	MCF-7	breast:
29	chr12:85969213..85970141-chr12:86036344..86037184,4	MCF-7	breast:

(count:1 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-ALX1-2	chr12:85988245-85988373	NONHSAT029750

No data

Variant related genes	Relation type
ENSG00000257855	TF binding region
ENSG00000263449	TF binding region
ENSG00000257855	CpG island
ENSG00000263449	CpG island
ENSG00000263449	chromatin interactions
ENSG00000170836	chromatin interactions

Extended variants
information (count: 3517 )
Associated
traits (count: 66 )

Variant overlapped rSNPs/rCNVs (count:3517 , 50 per page) page: 1 2 3 4 5 6 7 ... 71

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs573964223	chr12:85902615-85902616	Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs561876109	chr12:85902642-85902643	Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs183932525	chr12:85902726-85902727	Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs573580425	chr12:85902753-85902754	Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs186310470	chr12:85902789-85902790	Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs562477534	chr12:85902790-85902791	Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs545339287	chr12:85902869-85902870	Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs533027756	chr12:85902888-85902889	Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs76054706	chr12:85902890-85902891	Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs199724173	chr12:85902898-85902899	Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs528715023	chr12:85902977-85902978	Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs555977464	chr12:85902992-85902993	Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs147211527	chr12:85902993-85902994	Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs190430255	chr12:85903004-85903005	Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs568703287	chr12:85903021-85903022	Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs529592524	chr12:85903028-85903029	Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs550921980	chr12:85903059-85903060	Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs182974739	chr12:85903094-85903095	Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs568926850	chr12:85903107-85903108	Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs539517912	chr12:85903183-85903184	Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs531191853	chr12:85903200-85903201	Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs566651792	chr12:85903224-85903225	Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs533795172	chr12:85903243-85903244	Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs73363863	chr12:85903248-85903249	Enhancers Active TSS Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
25	rs142823283	chr12:85903259-85903260	Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs146987179	chr12:85903264-85903265	Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs375793235	chr12:85903265-85903266	Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs556170007	chr12:85903403-85903404	Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs377239005	chr12:85903462-85903463	Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
30	rs138082773	chr12:85903554-85903555	Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
31	rs187014716	chr12:85903616-85903617	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs192996812	chr12:85903618-85903619	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs560028804	chr12:85903638-85903639	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs183053181	chr12:85903651-85903652	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs536912679	chr12:85903719-85903720	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs371133050	chr12:85903749-85903750	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs542387491	chr12:85903804-85903805	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs187697544	chr12:85903949-85903950	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs192409359	chr12:85904027-85904028	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs143730705	chr12:85904058-85904059	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs34012166	chr12:85904073-85904074	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs7488922	chr12:85904086-85904087	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
43	rs551459022	chr12:85904112-85904113	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs566806771	chr12:85904145-85904146	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs184774055	chr12:85904191-85904192	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs114935938	chr12:85904307-85904308	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs150578179	chr12:85904337-85904338	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs567478524	chr12:85904421-85904422	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs189607495	chr12:85904423-85904424	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs77342175	chr12:85904439-85904440	Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:66)

Disease	PMID	Source
Wilms tumour	21544195	CNVD
Esophageal cancer	21851588	CNVD
Lung cancer	20668451	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Ewing''s sarcoma	21437220	CNVD
Testicular germ cell tumor	18059402	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Medulloblastoma	21979893	CNVD
Malaria	21533027	CNVD
Chronic lymphocytic leukemia	22228453	CNVD
Basal cell lymphoma	17053054	CNVD
Chronic lymphocytic leukemia	21670202	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Autism	22495311	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Breast cancer	21949216	CNVD
Carcinoma ex pleomorphic adenoma	18828159	CNVD
Acute myeloid leukemia	16864856	CNVD
Cancer	21637783	CNVD
Glioblastoma multiforme	21080181	CNVD
Renal cell carcinoma	19461508	CNVD
Burkitt''s lymphoma	18698080	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Gastrointestinal stromal cancer	20470368	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Lung cancer	18438408	CNVD
Breast cancer	17899364	CNVD
Cancer	16751803	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
small cell lung cancer	20016488	CNVD
Melanoma	18172304	CNVD
Glioblastoma multiforme	21390271	CNVD
Cancer	20164919	CNVD
Metanephric adenoma	20802469	CNVD
Acute myeloid leukemia	21251322	CNVD
Prostate cancer	18632612	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Myeloproliferative neoplasm	20015882	CNVD
Breast cancer	22032731	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Ovarian cancer	21720365	CNVD
Acute myeloid leukemia	20729466	CNVD
Myelofibrosis	22110671	CNVD
Colorectal cancer	16272173	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Renal cell carcinoma	18194544	CNVD
lymphocytic leukemia	21291569	CNVD
Breast cancer	21364760	CNVD
Bipolar disorder	19114987	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD

Chromatin state (count:394 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr12:85902600-85903200	Enhancers	GM12878-XiMat	blood
2	chr12:85902600-85903600	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
3	chr12:85902600-85904000	Enhancers	Primary hematopoietic stem cells short term culture	blood
4	chr12:85902600-85904000	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
5	chr12:85902800-85903600	Enhancers	Primary B cells from peripheral blood	blood
6	chr12:85902800-85903800	Enhancers	Primary hematopoietic stem cells	blood
7	chr12:85902800-85903800	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
8	chr12:85902800-85903800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
9	chr12:85903000-85903800	Enhancers	Thymus	Thymus
10	chr12:85903200-85903600	Active TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
11	chr12:85903200-85903600	Flanking Active TSS	GM12878-XiMat	blood
12	chr12:85903600-85904200	Enhancers	GM12878-XiMat	blood
13	chr12:85903600-85911400	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
14	chr12:85908200-85908600	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
15	chr12:85908600-85908800	Enhancers	HUES48 Cell Line	embryonic stem cell
16	chr12:85908600-85912400	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
17	chr12:85909200-85909400	Enhancers	iPS-18 Cell Line	embryonic stem cell
18	chr12:85909400-85912200	Weak transcription	iPS-18 Cell Line	embryonic stem cell
19	chr12:85910000-85913000	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
20	chr12:85910600-85911000	Enhancers	ES-I3 Cell Line	embryonic stem cell
21	chr12:85910600-85911000	Enhancers	HUES48 Cell Line	embryonic stem cell
22	chr12:85910600-85911000	Enhancers	NHEK	skin
23	chr12:85910600-85911200	Enhancers	ES-WA7 Cell Line	embryonic stem cell
24	chr12:85910800-85911000	Enhancers	HUES6 Cell Line	embryonic stem cell
25	chr12:85910800-85911000	Enhancers	iPS-15b Cell Line	embryonic stem cell
26	chr12:85910800-85911200	Enhancers	HUES64 Cell Line	embryonic stem cell
27	chr12:85911000-85912200	Weak transcription	HUES48 Cell Line	embryonic stem cell
28	chr12:85911000-85912400	Weak transcription	iPS-15b Cell Line	embryonic stem cell
29	chr12:85911000-85912600	Weak transcription	ES-I3 Cell Line	embryonic stem cell
30	chr12:85911200-85912200	Weak transcription	HUES6 Cell Line	embryonic stem cell
31	chr12:85911200-85912200	Weak transcription	HUES64 Cell Line	embryonic stem cell
32	chr12:85911200-85912400	Weak transcription	ES-WA7 Cell Line	embryonic stem cell
33	chr12:85911400-85912800	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
34	chr12:85912200-85912800	Enhancers	HUES48 Cell Line	embryonic stem cell
35	chr12:85912200-85913800	Enhancers	HUES6 Cell Line	embryonic stem cell
36	chr12:85912200-85913800	Enhancers	HUES64 Cell Line	embryonic stem cell
37	chr12:85912200-85913800	Enhancers	iPS-18 Cell Line	embryonic stem cell
38	chr12:85912400-85912600	Enhancers	iPS-20b Cell Line	embryonic stem cell
39	chr12:85912400-85912800	Enhancers	ES-WA7 Cell Line	embryonic stem cell
40	chr12:85912400-85913200	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
41	chr12:85912400-85913200	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
42	chr12:85912400-85914000	Enhancers	iPS-15b Cell Line	embryonic stem cell
43	chr12:85912600-85913000	Flanking Active TSS	iPS-20b Cell Line	embryonic stem cell
44	chr12:85912600-85913800	Enhancers	ES-I3 Cell Line	embryonic stem cell
45	chr12:85912800-85913000	Flanking Active TSS	HUES48 Cell Line	embryonic stem cell
46	chr12:85912800-85913200	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
47	chr12:85913000-85913200	Enhancers	HUES48 Cell Line	embryonic stem cell
48	chr12:85913000-85913400	Enhancers	H1 Cell Line	embryonic stem cell
49	chr12:85913000-85913400	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
50	chr12:85913000-85913800	Enhancers	iPS-20b Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links